Pulmonary Thromboembolism
Herbert L. Fred, Shahzad Hashim, and Fady A. Joudah ach year in the United States, an estimated 5 million people suffer an episode of venous thrombosis, 1 650,000 experience a pulmonary embolic event, 2 and as many as 200,000 of them die. 3 Although pulmonary thromboembolism (PTE)* occurs in all age groups, most victims are middle-aged or older. 4 A concurrent illness usually is present, but PTE can strike seemingly healthy, active persons, 5 including children 6 and adolescents.
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Risk Factors
Numerous factors-acquired 8 and inherited [9] [10] [11] [12] -can predispose a person to venous thromboembolism. The acquired factors with strong predictive values are major trauma (especially to the lower extremities and pelvis), major general surgery, hip or knee replacement, and paralytic spinal cord injury. 8 Those with moderate predictive values include respiratory or congestive heart failure, immobility (from medical illness, surgical procedures, or prolonged sitting), previous venous thromboembolism, malignancy, 13 antiphospholipid antibodies, 14 central venous lines, 15, 16 oral contraceptive therapy, 17, 18 hormone replacement therapy, 19 and chemotherapy. 20 Those with weak predictive values are obesity, pregnancy, 21, 22 use of antipsychotic drugs, 23, 24 increasing age, varicose veins in the legs, and myeloproliferative disorders.
Of the various inherited factors, mutations in the factor V gene (factor V Leiden) and the prothrombin (factor II) gene are the most common. 10 Factor V Leiden is present in about 5% of healthy people of northern European ancestry 9 but almost never affects black or Asian people. 11 Most carriers of this defect are heterozygous with a relatively low risk for thrombosis. 9, 12 In the homozygous carriers, however, the risk is signifi cantly higher. 25 Other inherited factors-all rareinclude increased levels of clotting factors VIII, IX, and XI, [9] [10] [11] hyperhomocysteinemia, 26, 27 dysfi brinogenemia, and defi ciencies of antithrombin III, protein C, and protein S.
Two recently reported fi ndings are noteworthy. Rates of deep vein thrombosis and PTE in Asians/Pacifi c Islanders are markedly lower than in whites and African Americans. 28 Explanations for this phenomenon remain speculative. 29 Additionally, the use of tamoxifen as prophylaxis against breast cancer carries an increased risk of venous thromboembolism. 30 The benefi ts of tamoxifen, however, far outweigh this particular risk. 31 
Sources of Emboli
For several reasons, statistics vary as to the sites from which pulmonary emboli originate. The mere presence of thrombi in peripheral veins, right atrium, or right ventricle does not prove that these sites are the source of such emboli. Indeed, thrombi sometimes exist in these areas when no pulmonary emboli are evident. Moreover, once a clot becomes detached, its site of origin may appear normal when examined by imaging techniques or at autopsy.
These points aside, most pulmonary emboli arise from veins in the lower extremities 32 or pelvis. 33 Occasionally, the heart is the source 34 ( Fig. 104.1C ), particularly in patients with septic pulmonary emboli from right-sided endocarditis. 35 Other sites of origin at times are the inferior vena cava, veins in the upper extremities, 36 prostatic venous plexus, 37 renal veins, 38 and veins of the cerebral sinuses and nasopharynx. E * PTE as used here refers to acute or subacute pulmonary thromboembolism with or without resultant infarction of the lung. The term does not include septic pulmonary embolism or chronic majorvessel pulmonary hypertension.
Pulmonary Thromboembolism Without Infarction
Dyspnea without orthopnea is the most common and important symptom. 4 It is often sudden in onset, progressing at times to gasping respirations. Frequently, however, the dyspnea is mild and fl eeting. Chest pain is rare; when present, it is typically dull and retrosternal and usually refl ects occlusion of major pulmonary arteries. [39] [40] [41] Wheezing respirations, ordinarily transient and occasionally recurrent, can be a her-alding feature. 42 Neurologic abnormalities, such as syncope, convulsions, restlessness, anxiety, stupor, coma, and weakness or paralysis of limbs, predominate in about 5% of the cases and may be the fi rst, the most prominent, or the only manifestation. 43 Unexplained apprehension and a sense of impending doom are common. 44 Rarely, the patient experiences a sudden strong urge to defecate or may faint or die during defecation. 45 Tachycardia 44 and tachypnea 46 are frequent and often disproportionately severe. Signs of venous thrombosis in the legs, such as pain, heat, discoloration, or enlargement, develop in less than half of the patients and may not become evident for days or even months after the onset of pulmonary symptoms. 47 Cyanosis may appear when embolism is massive or there is coexisting cardiopulmonary disease, shock, or both. Hypotension is relatively uncommon. Characteristically, it is of short duration, but if persistent, it indicates that the diagnosis is wrong or that embolism is massive. In some cases, sudden, profound, or prolonged shock is the only indication of PTE. Acute cor pulmonale can result from massive PTE and may be accompanied by an accentuated pulmonic valve closure sound, right ventricular gallop rhythm, or increased jugular venous pressure.
One point merits special attention. Signs of PTE without infarction may regress spontaneously just as dramatically as they appear. In these cases, the patient seems well one minute and moribund the next, only to recover rapidly.
Pulmonary Thromboembolism with Infarction
Fewer than 10% of pulmonary thromboemboli lead to infarction of the lung. 48 Pleuritic pain emerges in only half of these patients and may be sudden or gradual in onset and mild or severe. 49 Hemoptysis occurs in about one third of these patients. 4 At fi rst, the expectorant is bright red; it then appears as dark clots, and fi nally as dark brown, semiliquid material. Fever of varying duration and pattern is common. 50, 51 Temperatures usually range between 100°F and 103°F but can reach 105°F in the absence of demonstrable infection ( Fig. 104.2) . Cough is uncommon and, when present, is intermittent and mild. 52 Pleural friction rub, audible in only about one fourth of these patients, 49 sometimes precedes radiographic evidence of pulmonary infarction. Rales and signs of pleural effusion are common, but classic signs of consolidation are rare. Jaundice can develop when the infarction is extensive or when congestive heart failure, hepatic disease, or both are present.
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Radiographic Findings
The radiographic patterns of PTE depend on the size, number, and distribution of the thromboemboli, the preexisting anatomic and functional status of the heart and lungs, and the frequency with which chest radiographs are obtained. Before frank infarction develops, the chest radiograph typically shows no abnormality. This is true even when one suspects PTE and searches specifi cally for its signs. In some cases, however, one or both main pulmonary arteries become enlarged (Figs. 104.1A, 104.3A, and 104.4), with decreased peripheral vascular markings in the affected portions of lung (oligemia) and engorged vessels in the non affected areas (pleonemia) (Fig. 104.4) . The hemidiaphragm on the involved side may be elevated consequent to atelectasis.
After infarction develops, the chest radiograph almost always shows some abnormality, typically within 24 hours (Fig. 104.5 ). Rarely, it takes up to 5 days for an abnormality to appear. 54 Any segment of lung may be involved, but the lower lobes, especially the right, are the usual sites. 55 Atelectasis and small pleural effusions are common, but large pleural effusions, some loculated, 56 may also occur. Parenchymal densities range in size from mere visibility to that of an opacifi ed lobe ( Fig. 104.2) . Their patterns are so diverse that no shape necessarily suggests or excludes pulmonary infarction. Traditional teaching that the typical radiographic appearance of a pulmonary infarct is that of a "wedge-shaped" shadow has served more to confuse than to facilitate the diagnosis of pulmonary infarction.
The radiographic fi ndings of pulmonary infarction can mimic those of many diseases, especially pulmonary infection. 51, 56 Sometimes it simulates cancer 57 ( Fig. 104 .6A,C), and, if cavitation occurs, the lesion can be mistaken for pulmonary abscess ( Fig. 104.2 ). Infarction involving an upper lobe occasionally masquerades as pulmonary tuberculosis. Septic pulmonary embolism-an infectious process, not an obstructive process-typically appears as small, patchy lesions FIGURE 104.2. Chest radiograph of a 61-year-old man with chronic heart failure, hemoptysis, fever of 105°F, and a total leukocyte count of 40,000/mm 3 . Note the cardiomegaly, opacifi ed right lower lobe with an air-fl uid level (arrow), and enlarged right pulmonary artery. Autopsy the next day showed a large thromboembolus occluding the right pulmonary artery with extensive infarction and cavitation of the right lower lobe. There was no evidence of pulmonary infection.
FIGURE 104.3.
A previously healthy 37-year-old man had a sudden syncopal episode followed by persistent dyspnea. Six hours later, he died. (A) Chest radiograph shows prominence of the central pulmonary arteries with abrupt tapering of the lower lobe branches and possible enlargement of the pulmonary outfl ow tract and right atrium. (B) Electrocardiogram demonstrates sinus tachycardia, prolonged QT interval, and anterior T-wave changes consistent with ischemia or acute right heart strain. Autopsy disclosed a saddle embolus at the bifurcation of the pulmonary arterial trunk extending into and obstructing the right and left pulmonary arteries. (frequently cavitary) scattered throughout the lungs, often mimicking metastases or tuberculosis. 35 Chronic major vessel thromboembolic pulmonary hypertension usually results in clear lung fi elds. In some patients, however, the right atrium and right ventricle are dilated, with enlargement or asymmetry of the central pulmonary arteries.
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Electrocardiographic Findings
Electrocardiographic abnormalities are commonly absent and always nonspecifi c. Moreover, preexisting cardiac or pulmonary disease can modify or prevent the changes that might otherwise suggest PTE. When abnormalities do appear (Table 104 .1), they are often fl eeting and may go undetected unless multiple tracings are made within a short time. The transient nature of these alterations is characteristic, however, and serves as an important clue to PTE. Sinus or supraventricular tachycardias, ST-segment and T-wave changes in the right precordial leads, and right bundle branch block are the most frequent electrocardiographic abnormalities (Figs. 104.3B, 104.7A, and 104.8A). But even when the embolism is acute and massive, the electrocardiogram may show no signs of right ventricular strain. 59 In that regard, a Qr in lead V 1 is closely related to right ventricular dysfunction. 60 In patients who have obliterative pulmonary hypertension from recurrent small pulmonary emboli 61 or from chronic major vessel pulmonary thromboemboli, 58 the electrocardiogram may be normal or may show right-axis deviation, P pulmonale, or a pattern of right ventricular hypertrophy and strain. normal value (<500 µg/L), however, makes PTE, [73] [74] [75] [76] as well as deep vein thrombosis, [77] [78] [79] [80] most unlikely. Blood levels of troponin and brain natriuretic peptide correlate closely with right ventricular function. [81] [82] [83] In that light, normal values of these biomarkers suggest normal right ventricular function and predict good patient outcome. 81, 84, 85 Elevated levels, however, signal right ventricular impairment for which echocardiographic evaluation should be considered.
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Diagnosis
Constant awareness of PTE is the key to early diagnosis. If one waits for hemoptysis, pleural friction rub, signs of venous disease in the legs, pulmonary parenchymal infi ltrates, or abnormal electrocardiographic patterns to develop, most cases will escape recognition. By contrast, the diagnosis should never be doubted or rejected simply because of high fever, leukocytosis, normal jugular venous pressure, normal arterial blood gas analysis, "atypical" pulmonary lesions, or failure to detect the source of emboli. 
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Miscellaneous Laboratory Findings
Results of routine laboratory tests in patients with PTE are nonspecifi c. The total leukocyte count usually is normal or slightly elevated 62 ; however, in the presence of massive, bland necrosis of pulmonary tissue, it may reach 40,000/mm 3 ( Fig.  104. 2). The sputum, if examined soon after infarction develops, commonly shows many erythrocytes but few leukocytes or organisms. Pleural fl uid, when present, is bloody in 50% 49 to 65% 63 of the cases and may be a transudate or an exudate. 63 Arterial blood gas analysis often shows hypoxemia, hypocarbia, respiratory alkalosis, and an increase in the P(A − a)O 2 gradient. [64] [65] [66] Yet up to a fourth of patients with documented PTE do not have hypoxemia while breathing room air, [65] [66] [67] and an increase in the P(A − a)O 2 gradient can occur in conditions other than PTE. 66, 67 Hence, a normal blood gas analysis does not exclude PTE, 68 and abnormal results, in and of themselves, do not appreciably increase the likelihood of PTE. 69 Plasma levels of D-dimer, a degradation product of crosslinked fi brin, are nearly always increased with PTE. 70 But this increase can occur in a wide variety of settings. [71] [72] [73] A Findings that should alert the physician to the possibility of PTE are fever of unknown origin and fever that does not respond to antibiotic therapy (especially in patients who have congestive heart failure or in those who are postpartum or postsurgical); congestive heart failure that increases rapidly in severity or is unresponsive to the usual therapeutic measures; dyspnea or wheezing of unknown cause; paroxysmal arrhythmias; unexplained sinus tachycardia; appearance of an "abscess" on chest radiograph; bloody pleural effusion; and sudden, profound, or prolonged shock.
If initial studies are inconclusive and the suspicion for PTE remains, additional testing is indicated. In this circumstance, physicians traditionally have turned to the ventilation/perfusion (V/Q) lung scan. [88] [89] [90] [91] [92] [93] Perfusion scans image the distribution of intravenously injected macroaggregates of albumin labeled with technetium-99m ( 99m Tc). Distribution of these macroaggregates in a segment of lung is proportional to the relative pulmonary blood fl ow to that segment.
Ventilation scans involve the inhalation and washout of a tracer, usually xenon-133 ( 133 Xe) gas. This technique determines regional pulmonary ventilation. Reduction of both ventilation and perfusion generally implies parenchymal or bronchial disease, 94 whereas ventilation without perfusion points to pulmonary vascular obstruction. 95 A normal lung scan is as reliable as a normal pulmonary arteriogram in ruling out PTE. 90, 96, 97 Nevertheless, most scans are reported as showing high, intermediate, or low probability. 89, 91, 92, 94, 95 These probabilities have distinct limitations. The Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED), 92 in comparing V/Q scanning with pulmonary arteriography, found that only 41% of patients with arteriographically proven PTE had a high-probability lung scan. Other studies have shown similar results. 98, 99 Furthermore, from 15% to 30% of patients with low-probability scans do, in fact, have PTE. 92, 94, 95, 97, 98 For these reasons, newer imaging techniques have gained popularity. [100] [101] [102] [103] [104] [105] [106] [107] Contrast-enhanced spiral computed tomography (CT angiography) images the pulmonary vessels directly. Thromboemboli appear as fi lling defects within the opacifi ed arteries 107, 108 ( Fig. 104.7C ). This test has the advantages of being minimally invasive, of identifying disorders that can masquerade as PTE, [109] [110] [111] and of monitoring the resolution of established blood clots. 112 In addition, it has the capacity to detect right ventricular enlargement, which, in and of itself, predicts poor patient outcome. 113, 114 Its accuracy for detecting thromboemboli proximal to the subsegmental level approaches that of pulmonary arteriography. 112, [115] [116] [117] Nevertheless, CT angiography has certain limitations. It requires breath-holding, which poses diffi culty for the tachypneic patient. 107, 115, 118 It also exposes the patient to high doses of radiation. 119 And it does not reliably identify clots in the periphery of the lungs. 108, 118, 120, 121 Such peripheral clots may be important, however, because they could adversely affect the outcome, especially in patients with underlying cardiopulmonary disease. 108, 121 These clots could also lead to chronic thromboembolic pulmonary hypertension. 121, 122 Better information on the clinical signifi cance of these clots can be expected with the increasing availability of multislice spiral CT. 108, 121, 123 Compression venous ultrasonography is the standard method for diagnosis of proximal deep vein thrombosis. [124] [125] [126] [127] [128] [129] A positive fi nding represents surrogate evidence of PTE. 93, 95, 104, [130] [131] [132] [133] This test, however, does not reliably detect calf vein thrombi, which pose the threat of proximal extension with subsequent embolization. Therefore, a repeat study 1 to 2 weeks after clinical signs develop may prove worthwhile in a small percentage of patients. [127] [128] [129] 134 Computed tomographic venography accurately identifi es venous thrombi in the abdomen, pelvis, thigh, and calf 135 ; however, the radiation it delivers to the reproductive organs is a considerable drawback. 136 The exact role of this procedure awaits further study.
Contrast venography is the gold standard for diagnosis of deep vein thrombosis. [137] [138] [139] It is particularly useful when noninvasive studies are inconclusive, 128, 129 as in asymptomatic postoperative patients suspected of having proximal deep vein thrombosis and in patients thought to have calf vein thrombosis or recurrent deep vein thrombosis. 128, 129, 138, 140 Pulmonary arteriography is the most reliable means of establishing the presence of pulmonary thromboemboli and determining their location and extent. 92, 95, 99 Nowadays, however, use of this procedure is limited to situations in which the clinical suspicion of PTE persists despite normal results from noninvasive studies. 104, 132, 133 The arteriographic fi ndings of PTE consist of completely obstructed pulmonary arteries (Figs. 104.1B, 104.6B, and 104.9), intraarterial fi lling defects ( Fig. 104.9 ), decrease in volume of affected lung segments ( Fig. 104.9 ), and changes in arterial caliber proximal or distal to the embolus. [141] [142] [143] By contrast, the arteriographic fi ndings of chronic pulmonary thromboembolism refl ect the structural changes resulting from partial resolution of the embolic material. These changes characteristically appear as intraarterial webs, pouch-like fi lling defects, or various intimal irregularities. [144] [145] [146] Echocardiography is valuable in detecting right ventricular dysfunction, a fi nding not always apparent clinically. [147] [148] [149] This fi nding, however, correlates with increased mortal- ity 150, 151 and should prompt immediate consideration of thrombolytic therapy. 152, 153 Moreover, assessing right ventricular function with this technique is an excellent means of monitoring therapeutic effi cacy. [154] [155] [156] Echocardiography can also detect a patent foramen ovale, a condition that places patients with PTE at increased risk of dying. 157 Additionally, this test can identify diseases that masquerade as PTE, such as acute cardiac tamponade and dissecting hematoma of the aorta.
The echocardiographic signs of PTE include dilated right atrium, dilated hypokinetic right ventricle, fl attening or paradoxical motion of the interventricular septum, and Doppler evidence of tricuspid or pulmonary regurgitation. 155, 156, [158] [159] [160] Regional right ventricular dysfunction with normal motion of the apical wall is another strong indication. 161 In addition, the echocardiogram may show clots in the right atrium (Fig. 104.7B ) or right ventricle 162 and, occasionally, in the central pulmonary arteries. 160, 163 Gadolinium-enhanced magnetic resonance (MR) angiography images the pulmonary vessels directly but has a sensitivity lower than that of spiral CT angiography. 107, [164] [165] [166] [167] It also takes a long time to perform. Nevertheless, this procedure is free of ionizing radiation and does not require iodinated contrast material. 107, 168 It is particularly useful, therefore, in documenting venous thrombosis in the pelvis and lower limbs of pregnant patients, orthopedic patients, and those with renal insuffi ciency or allergy to iodine. 107, 108, 167, 169, 170 Percutaneous angioscopy 171 and intravascular ultrasound [172] [173] [174] do not have an established role in the diagnosis of PTE. They are, however, useful in the preoperative evaluation of patients with chronic thromboembolic pulmonary hypertension.
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Differential Diagnosis
The manifestations of PTE are so protean that even experienced clinicians occasionally mistake the illness for some other disorder. In addition, many other disorders often masquerade as PTE (Table 104. 2). In this section, we show how confusion in diagnosis comes about, and, when possible, suggest simple means of resolving the issue. We also indicate when specialized diagnostic procedures are indispensable for proper management.
Parenchymatous Respiratory Disorders
Pneumonia Both pulmonary infarction and bacterial pneumonia can cause dyspnea, tachypnea, cough, pleuritic pain, fever, hemoptysis, and leukocytosis. Moreover, both can cause similar abnormalities on chest radiograph. 51 To minimize diagnostic error, physicians should consider both disorders whenever they make a tentative diagnosis of either, particularly when the process involves the lower lobes, especially the right. Accurate clinical differentiation of pulmonary infarction from bacterial pneumonia often takes several days and may be impossible without imaging of the pulmonary arteries. Therefore, as long as the diagnosis is uncertain, we favor treatment for both conditions. Certain features are useful in distinguishing between these two illnesses. Patients with bacterial pneumonia frequently experience gradually increasing malaise followed by shaking chills and a cough productive of purulent sputum.
Physical signs of lung consolidation are common. By contrast, patients with pulmonary infarction often become ill with dramatic suddenness, seldom have a troublesome cough, never experience true shaking chills (unless the emboli are septic), and almost never show physical signs of consolidation. Parenchymal infi ltrates that appear fi rst in one lung and then the other or "pneumonia" unresponsive to therapy suggests pulmonary infarction.
A pleural friction rub is of no value in differentiating these disorders unless it appears in the absence of parenchymal infi ltrates on chest radiograph. In such cases, if the patient is well hydrated, pneumonia is unlikely, and the prime considerations would be early pulmonary infarction, fractured rib, viral pleuritis, and subdiaphragmatic infl ammation.
Sputum examination is particularly helpful in differentiating bacterial pneumonia from pulmonary infarction. In pneumonia, the sputum classically is purulent, is occasionally foul smelling, and may contain bright red fl ecks of blood. Gram stain typically shows many bacteria. Conversely, early in the course of pulmonary infarction, sputum (when present) usually is frankly bloody with few bacteria or infl ammatory cells. Blood cultures often yield the causative microorganism in patients with bacterial pneumonia but show no growth in patients with PTE.
The total leukocyte count may be normal or high in both PTE and bacterial pneumonia.
Pleural fl uid in PTE is often sanguineous and characteristically sterile. In bacterial pneumonia, however, it rarely is frankly bloody and often harbors the causative microorganism. The specifi c gravity and protein concentration of the pleural fl uid are not distinctive for either disorder.
Imaging of the pulmonary arteries is the most specifi c means of differentiating bacterial pneumonia from pulmonary infarction. The pulmonary arteries in pneumonia-in contrast to PTE-show no fi lling defects or obstruction. 51 Pyogenic Abscess, Neoplasm, Granulomatous Infection, and Amebiasis These disorders, like PTE, can manifest fever, cough, dyspnea, hemoptysis, and pleuritic pain. In addition, like PTE, their radiographic features may include any combination of enlarged hilum, "mass lesion," parenchymal infi ltrate, cavity (with or without an air-fl uid level), 175, 176 and pleural effusion. Correct diagnosis, therefore, often requires bronchoscopy, pulmonary-artery imaging, pleural biopsy, or thoracotomy.
Obstructive Pulmonary Disease
Obstructive pulmonary disease, as well as PTE, can cause wheezing, breathlessness, cough, hemoptysis, fever, and cyanosis. In addition, the chest radiograph in either disorder may show prominence of one or both main pulmonary arteries, together with localized or diffuse zones of increased radiolucency in which the peripheral vascular markings are diminished or absent. Moreover, both disorders may manifest electrocardiographic evidence of supraventricular arrhythmias, right-axis deviation, or a pattern suggesting right ventricular overload. In such instances, purulent sputum and hypercapnia suggest obstructive pulmonary disease, whereas hypocapnia favors PTE. Because perfusion defects occur in both conditions, lung scanning has limited usefulness, and CT angiography 101, 102 may become necessary.
Atelectasis
Both atelectasis and PTE are common in bedridden and postoperative patients. Each can also cause dyspnea, tachypnea, and cyanosis, together with rales and decreased breath sounds over the involved areas of lung. Furthermore, these disorders may cause similar radiographic changes, such as segmental collapse. Marked radiographic improvement after tracheobronchial suction or bronchoscopy favors atelectasis alone.
Asthma
Common to PTE and bronchial asthma are recurrent attacks of wheezing, dyspnea, and anxiety, associated with either a normal-appearing chest radiograph or one that shows scattered pulmonary parenchymal infi ltrates. Cyanosis and signs of rapidly developing pulmonary hypertension may also occur in both conditions. A long-standing history of atopy, together with elevated blood eosinophil count, tenacious and occasionally purulent sputum, or prompt therapeutic response to bronchodilators, supports a diagnosis of bronchial asthma. If, however, the patient is acutely ill, the diagnosis is in doubt, and precise differentiation is mandatory, imaging of the pulmonary arteries may become necessary.
Pleural and Congenital Respiratory Disorders
Viral
Epidemic pleurodynia (also called epidemic myalgia, devil's grip, and Bornholm's, Daae's, or Sylvest's disease) is an acute enteroviral infection usually caused by group B coxsackieviruses and generally occurring in epidemics. Like early pulmonary infarction, it produces paroxysms of severely discomforting intercostal muscle spasms, pleuritic pain, pleural friction rub, and a normal chest radiograph. Development of bloody sputum, pulmonary parenchymal infi ltrates, or both, signals PTE, whereas a cluster of cases of pleurisy with persistently normal chest radiographs points to epidemic pleurodynia.
Tuberculosis and Neoplasm
These illnesses, like PTE, can present with pleuritic pain, pleural friction rub, and grossly bloody pleural effusion. Defi nitive diagnosis rests on bacteriologic and histologic examination of the pleura and associated effusion.
Systemic Lupus Erythematosus
Patients with systemic lupus erythematosus occasionally exhibit sudden breathlessness, tachypnea, hyperpnea, tachycardia, cyanosis, pleuritic pain, pleural friction rub, and pleural effusion, accompanied at times by pulmonary parenchymal infi ltrates and hemoptysis. In this circumstance, there is no consistent clinical means of distinguishing between systemic lupus erythematosus per se and concomitant PTE. Therefore, we sometimes resort to imaging of the pulmonary arteries for guidance in managing these patients.
Agenesis of the Pulmonary Artery
Congenital absence of a main branch of the pulmonary artery (usually the left) can lead to recurrent hemoptysis and dyspnea simulating PTE. In almost all cases, however, fi ndings on conventional chest radiograph are suffi ciently characteristic to permit recognition of this syndrome. 177 The fi ndings consist of decreased volume of the affected lung with ipsilateral shift of the heart and mediastinal structures, absence of normal hilar shadow on the involved side, and plethora of the contralateral lung. Exact diagnosis requires visualization of the pulmonary arteries.
Cardiovascular Disorders
Myocardial Infarction
Often PTE mimics myocardial infarction (MI), particularly in the fi rst few hours after the embolic episode and before distinct clinical or radiographic signs of pulmonary infarction develop. To complicate matters, PTE occasionally is a sequel of MI, 178 and MI occasionally results from the systemic hypotension and pulmonary hypertension brought about by PTE. Certain features, however, are helpful in distinguishing between these two entities.
One good way of differentiating these disorders is to correlate the patient's blood pressure with the electrocardiogram. If hypotension develops concomitantly with or after the onset of chest pain, and the accompanying electrocardiogram does not show defi nite or strongly suggestive evidence of acute MI, cardiac necrosis is most unlikely. In contrast, when PTE causes hypotension, the electrocardiogram typically shows only sinus tachycardia and nonspecifi c T-wave changes or, sometimes, right-heart strain.
The duration of hypotension is another important diagnostic clue. Hypotension from MI ordinarily persists and usually requires vasopressor therapy. By contrast, hypotension from PTE ordinarily is transient and disappears within minutes to a few hours, often without the aid of vasopressors. If prolonged, hypotension indicates massive obstruction to pulmonary blood fl ow with consequent decrease in cardiac output.
Finally, two contrasting features of PTE and MI warrant emphasis. Patients with PTE characteristically have dyspnea out of proportion to the degree of pain, hypotension, cyanosis, or radiographic changes. They may also appear moribund one minute and nearly well the next. Conversely, in patients with acute MI, dyspnea frequently is absent and, when present, usually refl ects the degree of associated pulmonary vascular congestion. And once patients with MI appear moribund, they rarely recover spontaneously or rapidly.
Congestive Heart Failure
Features common to both congestive heart failure and PTE are dyspnea, wheezing, apprehension, cyanosis, tachycardia, rales in the lung, hypotension, pleural effusion, bright red sputum, and elevated jugular venous pressure. To complicate the picture, congestive heart failure predisposes patients to PTE, and PTE sometimes precipitates and is responsible for the persistence of congestive heart failure.
Although clinical differentiation of these two disorders may be quite diffi cult, points favoring PTE are distinct clots of blood in the sputum, a normal heart size, and no pulmonary congestion on chest radiograph. Echocardiographic demonstration of contractile dysfunction predominantly of or limited to the left ventricle will usually establish a cardiac cause. Occasionally, imaging of the pulmonary arteries, direct measurement of pulmonary capillary pressure, or both may be necessary for exact diagnosis.
Pericarditis
When infarction of the lung develops contiguous with the pericardium, a pleuropericardial friction rub, electrocardiographic signs of pericarditis, or both may appear. A pericardial-like rub may also become audible in the area overlying a main pulmonary artery distended by massive thromboemboli. [39] [40] [41] 179 In our experience, the pericarditis induced by PTE is not associated with demonstrable pericardial effusion.
Acute Cardiac Tamponade
When acute cardiac tamponade presents with abrupt onset of dyspnea, tachypnea, tachycardia, cyanosis, distended neck veins, hepatomegaly, hypotension, and occasionally chest pain, it closely simulates massive PTE. Pulsus paradoxus, inspiratory distention of neck veins (Kussmaul sign), and distant heart sounds may also occur in either disorder. Because small amounts of pericardial fl uid accumulated rapidly can lead to signifi cant hemodynamic alteration without signifi cant cardiomegaly, chest radiographs may not be useful in differentiating these two processes. Correct diagnosis may require echocardiography, CT angiography, magnetic resonance angiography, or cardiac catheterization.
Dissecting Hematoma of the Aorta
Chest pain (usually severe and occasionally pleuritic), dyspnea, tachypnea, hypotension, neurologic manifestations, and even hemoptysis are features of dissecting hematoma of the aorta that simulate PTE. Additional diffi culty in diagnosis can develop if the hematoma ruptures into the pericardial sac, causing cardiac tamponade, or into the pleural space (usually the left), resulting in hemothorax. A hematocrit value of the pleural fl uid approaching that of the peripheral blood is evidence of a ruptured vessel and weighs heavily against pulmonary infarction. Widening of the aorta, mediastinum, or both on chest radiograph is another sign of dissecting hematoma. Precise diagnosis ordinarily requires echocardiography, CT angiography, magnetic resonance imaging, or a combination thereof.
Right-Sided Intracavitary Cardiac Lesions
When the ball-valve action of a right-sided cardiac thrombus or neoplasm impedes orderly fl ow of blood into the lungs, the patient may exhibit intermittent dyspnea, syncope, tachycardia, cyanosis, chest pain, arrhythmias, or various cardiac murmurs. Unlike the fi ndings in PTE, these signs and symptoms may change as the patient's position changes. If the lesion abuts the pulmonic valve, the pulmonic component of the second heart sound may be muffl ed. If the lesion becomes calcifi ed, it may be evident on chest radiograph. Echocardiography, however, is the most sensitive and reliable means of detecting right-sided intracavitary masses.
Neurologic Disorders
Because the neurologic manifestations of PTE are usually abrupt in onset and are often transient and recurrent, they commonly masquerade as cerebrovascular disease. 43 Conversely, cerebrovascular diseases, such as hemorrhagic infarction and subdural hematoma, may be associated with labored respirations, pulmonary parenchymal infi ltrates, 180 and electrocardiographic changes. 181 Therefore, distinguishing between these two conditions can be diffi cult. Findings suggestive of PTE are cardiorespiratory abnormalities or signs of phlebitis that appear in association with sudden, transient, or recurrent neurologic dysfunction. Another clue to PTE is syncope at rest. When this occurs, the patient usually is elderly, is bedridden, or has heart disease.
Psychiatric Disorders
It is easy to mistake PTE for a functional disorder when tachypnea, diaphoresis, apprehension, and feelings of suffocation are the major clinical features. Conversely, functional disorders can mimic PTE, particularly when spurious hemoptysis is part of the clinical picture. We have seen this diagnostic dilemma over a full spectrum, from fatal PTE masquerading as Munchausen syndrome* (Fig. 104.1 ) to true Munchausen syndrome prompting vena caval ligation for suspected PTE. Differentiation depends primarily on thorough probing of the patient's complaints and credibility and use of tests appropriate for the given situation.
Abdominal Disorders
Pulmonary infarction of the lower lobes often presents with signs and symptoms typical of disease in the upper abdomen. Diagnostic confusion increases when the initial chest radiograph is normal and imaging studies of the abdomen are negative. In such cases, serial chest radiographs will resolve the issue if PTE is the culprit (Fig. 104.5 ).
Infectious Disorders
Bacteremia
When bacteremia presents with breathlessness, hyperpnea, tachypnea, tachycardia, peripheral cyanosis, and hypotension, the clinical picture mimics that of PTE. Hints of bacteremia are high fever, shaking chills, warm dry skin, and an obvious source of infection. If the diagnosis remains unsettled and the chest radiograph shows no parenchymal disease, a normal lung scan excludes PTE.
Peritonitis
Postoperative peritonitis (Fig. 104.8B ) can simulate PTE when it causes sudden circulatory collapse, rapid respirations, cyanosis, and pleural friction rub without causing the usual signs of peritoneal infl ammation. Moreover, concomitant electrocardiograms may show changes consistent with those of massive PTE (Fig. 104.8A ). Clues to peritonitis in such cases are a progressive rise in the hematocrit value (indicating sequestration of fl uid in the peritoneal cavity), a low central venous pressure, or a purulent peritoneal aspirate.
Pulmonary-Renal Disorders
Goodpasture's Syndrome Recurrent dyspnea, hemoptysis, and transient pulmonary infi ltrates are features of Goodpasture's syndrome that mimic PTE. Despite such similarities, clinical separation of these two entities ordinarily is easy. Patients with Goodpasture's syndrome characteristically are young and previously healthy and have iron-defi ciency anemia along with ironfi lled macrophages in their sputum. They may also exhibit proteinuria, hematuria, and cylindruria. During the acute stages of hemoptysis, their chest radiographs commonly show ill-defi ned, bilateral nodular densities, usually in a perihilar distribution sparing the apices and bases. Between bouts of hemoptysis, a fi nely granular, reticular pattern of increased interstitial markings may develop throughout the lungs.
Wegener's Granulomatosis
Wegener's granulomatosis, like PTE, may give rise to breathlessness, pleuritic pain, hemoptysis, pleural friction rub, pleural effusion, and cavities in the lung. Ultimately, most of these patients show evidence of widespread, multisystem disease, especially nephritis. Defi nitive diagnosis requires histologic demonstration of granulomatous disease of the respiratory tract, necrotizing vasculitis, and focal glomerulitis.
Uremia
We and others 183 have observed patients with advanced uremia who exhibit apprehension, tachypnea, hyperpnea, wheezing, pleuritic pain, pleural friction rub, progressive cyanosis, and, occasionally, hemoptysis and hypotension. When these manifestations develop abruptly and demise is rapid, the similarity to PTE is remarkable. Our experience indicates that differentiating these entities may not be possible without an autopsy.
Hematologic Disorders
Acute Blood Loss
When internal blood loss is sudden and severe, it may present as syncope associated with air hunger, tachycardia, peripheral cyanosis, and hypotension. These same features may also herald massive PTE. Because both disorders can be fatal * A label applied to persons "who, in the absence of appropriate medical or surgical need, have made hospitalization a primary way of life." 182 if not treated promptly and appropriately, early correct diagnosis is essential. In that regard, a low central venous pressure favors hypovolemia, whereas an elevated central venous pressure with an accentuated pulmonic valve closure sound points to massive PTE.
Sickle Cell Disease
Patients with sickle cell disease often experience acute chest pain, accompanied at times by fever, dyspnea, tachypnea, hypoxemia, pulmonary parenchymal infi ltrates, and small pleural effusions. This so-called acute chest syndrome 184 presumably results from pulmonary infection or in situ pulmonary microthromboses. Whatever the cause, the clinical picture closely mimics that of PTE.
Differentiating these two illnesses is important, particularly from the standpoint of therapy. In sicklers, anticoagulation is relatively ineffectual and inferior vena caval interruption potentially harmful. Moreover, pulmonary arteriography is generally contraindicated, because the hypertonic radiographic contrast material might precipitate further sickling and aggravate the condition. Thus, initial management of these patients should be conservative, consisting of pain control, hydration, supplemental oxygen, and, if necessary, empiric antibiotics and partial exchange transfusion.
Disseminated Intravascular Coagulation
Like PTE, disseminated intravascular coagulation can cause fulminant dyspnea, cyanosis, neurologic abnormalities, and hypotension. In addition, like PTE, it tends to occur in obstetric and postsurgical patients. It may even be the presenting manifestation of unrecognized PTE. 185 Unlike PTE, however, disseminated intravascular coagulation commonly leads to purpuric skin lesions, proteinuria, hematuria, fragmented erythrocytes on peripheral blood fi lm, thrombocytopenia, and depletion of plasma coagulation factors.
Metabolic Disorders
Pheochromocytoma
This tumor can cause paroxysms of hypotension, tachycardia, tachypnea, sweating, peripheral cyanosis, cardiac murmur, fever, and leukocytosis. The patient may also seem well one minute, desperately ill the next, and then recover spontaneously and rapidly. So similar are these fi ndings to those of PTE that the true nature of the illness can be totally overlooked while lung scanning, 186 pulmonary arteriography, right heart catheterization, and even ligation of the inferior vena cava are carried out. 187 Clues to pheochromocytoma are hyperglycemia, signs of hypermetabolism, a history of hypotension, a pronounced sensitivity to the hypotensive effects of phenothiazines, or discovery of an abdominal mass.
Lactic Acidosis
Rarely, lactic acidosis leads to acute and increasingly severe signs of pulmonary hypertension simulating massive PTE. In one case, clinical evidence of PTE was so convincing that the surgeon did an emergency pulmonary arteriotomy but found no pulmonary emboli. 188 Any process responsible for decreased oxygenation of peripheral tissues coupled with low serum carbon dioxide content should alert the physician to the possibility of lactic acidosis. Demonstration of an extremely low arterial pH in association with excess blood lactate confi rms the diagnosis.
Particulate Matter Disorders
Fat Embolism
In a patient with recent fracture of the long bones, sudden development of respiratory disability, pulmonary parenchymal infi ltrates, central nervous system abnormalities, or combinations thereof, suggests fat embolism as well as PTE. The best clue to fat embolism in such cases is the appearance of a petechial rash over the anterior part of the shoulders, the anterosuperior portion of the chest, the base of the neck, the axillae and conjunctivae, or, occasionally, the abdomen and thighs. 189 When present, the petechiae typically emerge 24 to 36 hours after the injury, persist for 3 to 4 days, and then fade rapidly. Additional points favoring fat embolism are the onset of symptoms within hours to a few days after the injury; diffuse, bilateral, "snowstorm-like" densities on chest radiograph simulating pulmonary edema but without pleural effusion or cardiomegaly; a sharp drop in the hematocrit value consequent to intrapulmonary hemorrhage; increased erythrocyte aggregation and hemolysis; thrombocytopenia resulting from platelet aggregation; and demonstration of fat globules in the retinal arterioles, in the cerebrospinal fl uid, or on the surface of the urine.
More typical of PTE are symptoms beginning 1 to 3 weeks after the accident; localized and larger pulmonary parenchymal lesions, often with pleural effusion; pleural friction rub; and signs of venous thrombosis.
Clinical differentiation of fat embolism from PTE can be diffi cult and sometimes impossible. In such cases, imaging of the pulmonary arteries is the best means of resolving the problem.
Amniotic Fluid Embolism
Precipitous hypotension, often accompanied by cardiorespiratory embarrassment, is characteristic of amniotic fl uid embolism but occurs in PTE as well. Moreover, accurate premortem distinction between these two types of embolism may be impossible. Guides to amniotic fl uid embolism are multiparity; maternal age over 30 years; onset of symptoms late in labor, during delivery, or in the immediate postpartum period; diffi cult or prolonged labor; overweight or stillborn infant; radiographic signs of pulmonary edema; or coagulation defects such as thrombocytopenia, hypoprothrombinemia, and hypofi brinogenemia. By contrast, frank hemoptysis, pleural friction rub, signs of venous thrombosis, and oligemic lung fi elds suggest PTE.
Tumor Embolism
Pulmonary arterial tumor emboli can cause a clinical picture just like that of PTE. Knowledge that the patient has a malignancy offers little diagnostic help, because PTE is frequent in persons with cancer. Although cytologic examination of blood obtained from the pulmonary artery may show malignant cells, 190, 191 lung biopsy provides the best means of establishing the diagnosis. Recognizing a surgically curable lesion such as myxoma of the right atrium or right ventricle is particularly important; in that regard, echocardiography is indispensable.
Venous Air Embolism
Accidental introduction of air into a systemic vein may result from a variety of diagnostic, therapeutic, or surgical procedures. 192 The gas characteristically collects in the right ventricular outfl ow tract or occasionally in the pulmonary arterial tree and, if suffi cient in amount, provokes gasping respirations, cyanosis, chest pain, tachycardia, convulsions, and hypotension. In most cases, death or total recovery ensues within an hour after onset of symptoms. A unique but inconsistent diagnostic sign is a precordial "mill-wheel" murmur-a churning and splashing noise that masks the heart sounds. Palpation of air in the jugular veins or radiographic demonstration of air in the right ventricle provides additional diagnostic aid.
Treatment
The ideal treatment of PTE is prevention of the initial thrombus formation. [193] [194] [195] Such measures-used singly or in various combinations-include early full ambulation (especially for postoperative and postpartum patients), elastic stockings or intermittent pneumatic compression for bedridden persons and for those undergoing major operative procedures, 196 and anticoagulant medication for patients at particular risk for PTE. Current options for preventing deep vein thrombosis in hospitalized patients, 194, in patients discharged after lower extremity arthroplasty, 214, 215 and in pregnant women 21, 231 are listed in Table 104 .3. Once PTE has occurred, the type of therapy depends on the severity of the illness, the nature of any associated disease(s), the skill and experience of the physician, and the available facilities. Even considering these factors, it may be diffi cult, at times, to decide on a fi xed course of treatment, primarily because one cannot accurately predict in a given patient whether or when another embolus will occur, whether it will be clinically detectable, or how extensive it will be.
In addition to supportive measures, immediate anticoagulation with unfractionated or low-molecular-weight heparin is indicated (barring obvious contraindications). Heparin acts largely by binding to antithrombin III. 237 The resultant heparin-antithrombin III complex inactivates both thrombin and activated factor X. Because of the heterogeneous nature of unfractionated heparin, the response to therapy with this agent varies considerably. 238 Hence, frequent monitoring of the activated partial thromboplastin time (APTT) is necessary.
It is important to achieve a therapeutic threshold rapidly (i.e., an APTT ratio 1.5 times the control). [239] [240] [241] Failure to do so increases the risk of recurrent PTE. 242 We favor an intravenous bolus of 5000 to 10,000 U of unfractionated heparin followed by a continuous infusion of 1200 to 1500 U/h. Additionally, we recommend that the dose be adjusted every 4 to 6 hours, using the APTT value as a guide. The infusion should be continued for at least 5 days. 243 Low-molecular-weight heparin offers several therapeutic advantages over unfractionated heparin: longer half-life, more predictable anticoagulant activity, no need for laboratory monitoring, and lower incidence of thrombocytopenia. 216, [244] [245] [246] [247] [248] [249] [250] Moreover, its therapeutic effi cacy in proximal deep vein thrombosis 216, 245, 246 and in PTE 248, [251] [252] [253] [254] [255] [256] is equivalent to that of unfractionated heparin. It is administered subcutaneously in a dosage of 1.5 mg/kg once a day or 1 mg/ kg every 12 hours.
Treatment of PTE in pregnancy merits special attention. The patient should receive unfractionated or low-molecularweight heparin as the fi rst step. Unfractionated heparin is administered intravenously for 10 days in the manner previously described and continued subcutaneously throughout gestation. 21 The subcutaneous regimen of unfractionated heparin consists of approximately 20,000 U every 12 hours, adjusted to maintain the APTT at 1.5 times the control. The dosage of low-molecular-weight heparin is the same as that in nonpregnant patients and requires weight-based adjustment as pregnancy progresses. 257, 258 Both anticoagulants should be discontinued at the onset of regular uterine contractions. After delivery, anticoagulation with warfarin 21 or low-molecular-weight heparin 258 is appropriate for at least 6 weeks.
The cornerstone of long-term anticoagulant therapy is warfarin. 259 This drug inhibits the enzyme vitamin K epoxide reductase. As a consequence, body stores of vitamin K become depleted, the synthesis of coagulation factors II, VII, IX, and X impaired, and the prothrombin time prolonged.
Warfarin can be administered along with, or shortly after, initiating heparin therapy. 243, 260, 261 The usual recommended therapeutic range is an international normalized ratio (INR) of 2.0 to 3.0. 262 But in patients with the antiphospholipid antibody syndrome, the target INR is 3.5. 263 Because warfarin readily crosses the placenta, its use during pregnancy is contraindicated.
Levels of coagulation factor VII decrease within hours after the initiation of warfarin therapy. It takes about 5 days, however, for levels of the other coagulation factors to decrease. 259, 264 Therefore, heparin therapy should be continued for several days after the target INR has been reached.
The duration of anticoagulation varies according to the clinical setting. 265, 266 In patients with a defi nable and reversible cause of PTE (e.g., fractured pelvis, postoperative state, or postpartum), 3 months of therapy may suffi ce. 267 When the cause cannot be identifi ed, however, therapy should be continued for 6 months 262, 268, 269 or longer. 270, 271 In that regard, patients with a normal plasma D-dimer value, obtained 1 month after discontinuing anticoagulant therapy, have a low risk for subsequent venous thromboembolism. 272 Patients with recurrent PTE and those with the antiphospholipid antibody syndrome require lifelong anticoagulation. For patients with other underlying thrombophilic conditions, the duration of therapy remains uncertain. 264, 266, 273, 274 Thrombolytic therapy warrants immediate consideration in patients who are hemodynamically unstable from PTE. Such treatment promotes dissolution of clots much faster than that achieved with anticoagulants alone. 154, [275] [276] [277] [278] [279] The resultant decrease in clot burden relieves strain on the right ventricle, allowing cardiac function to improve. 154, 159, 280, 281 This therapy may also reduce the rate of recurrent PTE by dissolving the initiating thrombi. Proof of such an effect, however, is lacking. 282 Some patients who are hemodynamically unstable from PTE do not respond to thrombolytic therapy. In such cases, rescue pulmonary embolectomy may be lifesaving. 283 A number of patients with PTE are hemodynamically stable but have echocardiographic evidence of right ventricular dysfunction. Their management remains debatable. 284 Although thrombolytics in these patients often decrease morbidity, 148, 149, 153, 285 they fail to reduce mortality. 286 They do, however, improve the scintigraphic, echocardiographic, and angiographic fi ndings. 282, [287] [288] [289] One additional point warrants emphasis. When the patient is in shock and the clinical evidence points strongly to PTE, thrombolytics can be lifesaving and should be administered without seeking absolute diagnostic confi rmation. The potential benefi t of thrombolytics in such cases far outweighs the risk of signifi cant hemorrhage. 280, 290 Bedside transthoracic or transesophageal echocardiography in this setting is invaluable in demonstrating right ventricular pressure overload while excluding other diagnostic considerations, such as cardiac tamponade, left ventricular failure, and aortic dissection. 148, 280 Contraindications to thrombolytic therapy include active internal bleeding, multiple trauma, intracranial hemorrhage, and pregnancy. 275 All contraindications become relative, however, when the patient is dying of PTE. 
. Prophylaxis of venous thromboembolism*
Medical inpatients
Unfractionated heparin 5000 U twice daily 194, 197 (with or without GCS, IPC, or aspirin † 198, 199 ) or Low-molecular-weight heparin Enoxaparin 40 mg daily 200, 232 Intensive care unit Same as medical inpatients [201] [202] [203] General surgery Unfractionated heparin 5000 U twice daily [204] [205] [206] [207] or Low-molecular-weight heparin 207, 208 Enoxaparin 40 mg daily or Dalteparin 2500 to 5000 U daily 209, 210 229 or Adjusted-dose unfractionated heparin to maintain APTT ratio 1.5 times that of the control value 230 
Pregnancy
Adjusted-dose unfractionated heparin to maintain APTT ratio 1.5 times that of the control value 230 or Low-molecular-weight heparin Dalteparin 5000 U daily 231 Whereas the window for thrombolytic therapy in MI is but a few hours, [291] [292] [293] it is days to weeks in PTE. 154, 294 Of the three thrombolytic agents currently in use (Table 104 .4), recombinant tissue-plasminogen activator is the fastest acting and produces the fewest systemic reactions. No laboratory monitoring or dose adjustment is necessary, and heparin is not used during the infusion. Anticoagulation is mandatory, however, on completion of thrombolytic therapy.
Interruption of blood fl ow through the inferior vena cava, either totally (by ligation) or partially (by use of fi lters or various suturing techniques), merits serious consideration when anticoagulant therapy is contraindicated or when PTE recurs despite optimal anticoagulation. 60, 295, 296 Caval interruption is mandatory after pulmonary embolectomy. Additionally, in patients with suppurative pelvic thrombophlebitis and septic pulmonary emboli unresponsive to antibiotic or anticoagulant therapy, ligation of the inferior vena cava and both ovarian or spermatic veins may be lifesaving.
Vena caval fi lters are being used in a wide variety of clinical circumstances. [296] [297] [298] [299] [300] [301] [302] The most popular fi lters are the titanium Greenfi eld, the alternating hook Greenfi eld, the bird's nest, the Simon nitinol, and the Vena Tech types. 303 In some institutions, fi lters specifi cally designed for temporary use are also available. [304] [305] [306] [307] [308] When combined with standard anticoagulation therapy, caval fi lters may be more effective than anticoagulation alone in preventing PTE. 300 But this added protection is short-lived and has not been shown to decrease mortality. Furthermore, the incidence of deep vein thrombosis increases with long-term use of caval fi lters. 300 Therefore, indications for vena caval fi lters await better defi nition. 309 The role of pulmonary embolectomy remains controversial. Some authors have suggested that this procedure should be considered more often, [310] [311] [312] even in patients with no hemodynamic compromise. [311] [312] [313] Others have argued that the successful completion of pulmonary arteriography virtually precludes the need for embolectomy. 314 Still others have said that there are no indications for pulmonary embolectomy. 315 In our opinion, this operation is indicated when thrombolytic and anticoagulant agents are contraindicated or have failed, and the patient is either moribund or shows steady deterioration despite vigorous medical management. 316 Although conventional arteriography is still the best means of establishing the presence and precise location of surgically accessible pulmonary thromboemboli, CT angiography is now being used for this purpose. 311, 312 In emergent situations, however, diagnostic confi rmation is sometimes obtained only at operation. 311, 312 Transvenous pulmonary embolectomy with catheter suction is another method of treating critically ill patients with PTE. 317, 318 Its in-hospital mortality rate, however, varies from 9% to 30%. 319 Furthermore, catheter embolectomy is limited in its ability to remove thrombi that have already become adherent to the wall of the pulmonary artery. Nevertheless, techniques of this sort [320] [321] [322] offer promise for patients who, from old age and coexisting disease, are particularly poor surgical risks, do not have access to cardiopulmonary bypass facilities, or have contraindications to heparin and thrombolytic therapy.
Pulmonary artery thromboendarterectomy is currently the only effective therapy for patients with chronic major vessel thromboembolic pulmonary hypertension. 146, 323, 324 
Course and Prognosis
Pulmonary arteriograms performed serially have shown that major clots can resolve spontaneously and completely within 7 325 to 14 326 days. In one case, an embolus to a lobar artery resolved almost completely within 30 hours. 327 These observations help explain why most patients with PTE survive the initial episode, irrespective of the treatment given.
Deaths from PTE usually occur within the fi rst 2 weeks after diagnosis. 328 In fact, about 75% of these deaths occur within the fi rst hour of symptoms. 329 Most of the patients who die are either elderly or have a serious underlying illness, such as heart failure, chronic lung disease, or cancer. 122, 328, 330 Recurrence of PTE ranges from 3% to 19% 122, 276, 277, 329, 331 and varies according to the risk factors preceding the initial thrombosis. When these factors are ongoing (e.g., idiopathic PTE, cancer, or thrombophilic disorder), recurrence is four times as high as it is when the factors are transient (e.g., recent surgery). 331 The long-term outlook for patients with PTE depends largely on the nature and severity of any underlying disease. The prognosis is good for those without preexisting cardiopulmonary illness. 150, 156, 332 For example, during a 9-year follow-up study, 12 of 72 patients who had survived massive PTE died, but in no case did death result from chronic pulmonary hypertension or from recurrence of PTE. 333 By contrast, if the patient has echocardiographic evidence of pulmonary hypertension and right ventricular dysfunction after hospitalization, the long-term prognosis is poor. 156 Chronic thromboembolic pulmonary hypertension complicates about 5% of the cases of PTE 122,156 -an incidence much higher than was originally thought. 146 Patients affected are of younger age, manifest a large perfusion defect at presentation, or have idiopathic pulmonary embolism. 122 Although some battles have been won, the war against venous thrombosis and pulmonary embolism is far from over. This disease continues to pose problems for both the patient and the doctor. Its incidence is still uncertain, its diagnosis often in doubt, and its treatment unsettled.
Few conditions in medicine have been subjected to so much analysis with so little elucidation.
Michael E. DeBakey 334 Written in 1954, those words remain true today. 
